Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Ioanna Tsiligianni, Maria Kampouraki, Despo Ierodiakonou, Ioannis Poulonirakis & Polyvios Papadokostakis. (2019) COPD patients’ characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 547-556.
Read now
Read now
María Merino, Renata Villoro, Álvaro Hidalgo-Vega & Concepción Carmona. (2018) Social economic costs of COPD in Extremadura (Spain): an observational study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2501-2514.
Read now
Read now
Onur Turan, Julide Celdir Emre, Sami Deniz, Aysegul Baysak, Pakize Ayse Turan & Arzu Mirici. (2016) Adherence to Current COPD Guidelines in Turkey. Expert Opinion on Pharmacotherapy 17:2, pages 153-158.
Read now
Read now
Sven-Arne Jansson, Helena Backman, Eva Rönmark, Bo Lundbäck & Anne Lindberg. (2015) Hospitalization Due to Co-Morbid Conditions is the Main Cost Driver Among Subjects With COPD–A Report From the Population-Based OLIN COPD Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:4, pages 381-389.
Read now
Read now
Carl Victor Asche, Shelah Leader, Craig Plauschinat, Swetha Raparla, Ming Yan, Xiangyang Ye & Dave Young. (2012) Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 201-209.
Read now
Read now
José Luis Izquierdo, Antonio Martín, Pilar de Lucas, José Miguel Rodríguez-González-Moro, Carlos Almonacid & Alexandra Paravisini. (2010) Misdiagnosis of patients receiving inhaled therapies in primary care. International Journal of Chronic Obstructive Pulmonary Disease 5, pages 241-249.
Read now
Read now
Javier de Miguel Diez, Pilar Carrasco Garrido, Marta García Carballo, Angel Gil de Miguel, Javier Rejas Gutierrez, José M Bellón Cano, Valentín Hernández Barrera & Rodrigo Jimenez García. (2008) Determinants and predictors of the cost of COPD in primary care: A Spanish perspective. International Journal of Chronic Obstructive Pulmonary Disease 3:4, pages 701-712.
Read now
Read now
Marc Miravitlles. (2005) Health status and costs of exacerbations of chronic bronchitis and COPD: how to improve antibiotic treatment. Expert Review of Pharmacoeconomics & Outcomes Research 5:4, pages 423-435.
Read now
Read now
Articles from other publishers (36)
José Luis Izquierdo, Clara Lillian Oeste & Ignacio Hernández Medrano. (2023) Artificial Intelligence in Pneumology: Diagnostic and Prognostic Utilities. Archivos de Bronconeumología 59:2, pages 67-68.
Crossref
Crossref
Ferran Morell, Dirk Esser, Jonathan Lim, Susanne Stowasser, Alba Villacampa, Diana Nieves & Max Brosa. (2016) Treatment patterns, resource use and costs of idiopathic pulmonary fibrosis in Spain – results of a Delphi Panel. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Gemma Seda & Merc? Bernardo. (2016) Ahorro y costes potenciales de una intervenci?n para reducir la no-adherencia de los pacientes cr?nicos avanzados. PharmacoEconomics Spanish Research Articles 13:4, pages 149-153.
Crossref
Crossref
David de la Rosa, Miguel-Angel Martínez-Garcia, Casilda Olveira, Rosa Girón, Luis Máiz & Concepción Prados. (2016) Annual direct medical costs of bronchiectasis treatment. Chronic Respiratory Disease 13:4, pages 361-371.
Crossref
Crossref
Luz María Peña-Longobardo, Juan Oliva-Moreno, Álvaro Hidalgo-Vega & Marc Miravitlles. (2015) Economic valuation and determinants of informal care to disabled people with Chronic Obstructive Pulmonary Disease (COPD). BMC Health Services Research 15:1.
Crossref
Crossref
Job F M van Boven, Miguel Román-Rodríguez, Janwillem W H Kocks, Joan B Soriano, Maarten J Postma & Thys van der Molen. (2015) Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol. npj Primary Care Respiratory Medicine 25:1.
Crossref
Crossref
Marie Jakobsen, Niels Anker, Jens Dollerup, Peter Bo Poulsen & Peter Lange. (2013) Study on drug costs associated with COPD prescription medicine in Denmark. The Clinical Respiratory Journal 7:4, pages 328-337.
Crossref
Crossref
Marc Miravitlles, Antoni Sicras, Carles Crespo, Maribel Cuesta, Max Brosa, Jordi Galera, Raquel Lahoz, Marta Lleonart & Maria Isabel Riera. (2013) Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting. Therapeutic Advances in Respiratory Disease 7:3, pages 139-150.
Crossref
Crossref
Natasha Duborija-Kovacevic & Milica Martinovic. (2012) Evaluation of pharmacotherapy of obstructive airway diseases in the Montenegrin outpatient care: comparison with two Scandinavian countries. Multidisciplinary Respiratory Medicine 7:1.
Crossref
Crossref
José Luis Izquierdo Alonso & José Miguel Rodríguez Glez-Moro. (2012) Utilización excesiva de corticoides inhalados en la enfermedad pulmonar obstructiva crónica. Archivos de Bronconeumología 48:6, pages 207-212.
Crossref
Crossref
José Luis Izquierdo Alonso & José Miguel Rodríguez Glez-Moro. (2012) The Excessive Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumología (English Edition) 48:6, pages 207-212.
Crossref
Crossref
Claudio F. Donner, Johann Christian Virchow & Mirco Lusuardi. (2011) Pharmacoeconomics in COPD and inappropriateness of diagnostics, management and treatment. Respiratory Medicine 105:6, pages 828-837.
Crossref
Crossref
Javier de Miguel-D?ez, Pilar Carrasco-Garrido, Javier Rejas-Gutierrez, Antonio Mart?n-Centeno, Elena Gobartt-V?zquez, Valent?n Hernandez-Barrera, Angel Gil de Miguel & Rodrigo Jimenez-Garcia. (2011) Inappropriate Overuse of Inhaled Corticosteroids for COPD Patients: Impact on Health Costs and Health Status. Lung 189:3, pages 199-206.
Crossref
Crossref
Rune Nielsen, Ane Johannessen, Ernst Reidar Omenaas, Per Sigvald Bakke, Jan Erik Askildsen & Amund Gulsvik. (2011) Excessive costs of COPD in ever-smokers. A longitudinal community study. Respiratory Medicine 105:3, pages 485-493.
Crossref
Crossref
A. de Diego Damiá. (2010) Enfermedad pulmonar obstructiva crónica (I). Medicine - Programa de Formación Médica Continuada Acreditado 10:64, pages 4385-4392.
Crossref
Crossref
Claudio F Donner & Mirco Lusuardi. (2010) COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future. Multidisciplinary Respiratory Medicine 5:6, pages 437.
Crossref
Crossref
Marc Miravitlles, Max Brosa, Mar?a Velasco, Carlos Crespo, Elena Gobartt, Silvia Diaz & Nuria Gonz?lez-Rojas. (2009) An economic analysis of pharmacological treatment of COPD in Spain. Respiratory Medicine 103:5, pages 714-721.
Crossref
Crossref
J. L. Izquierdo, C. Barcina, J. Jiménez, M. Muñoz & M. Leal. (2009) Study of the burden on patients with chronic obstructive pulmonary disease. International Journal of Clinical Practice 63:1, pages 87-97.
Crossref
Crossref
Joan B. Soriano Ortiz, Pere Almagro & Jaume Sauleda Roig. (2009) Causas de mortalidad en la EPOC. Archivos de Bronconeumolog?a 45, pages 8-13.
Crossref
Crossref
R. Nielsen, M. Klemmetsby & A. Gulsvik. (2008) Economics of COPD: literature review and experiences from field work. The Clinical Respiratory Journal 2, pages 104-110.
Crossref
Crossref
José Luis Izquierdo Alonso & José Miguel Rodríguez González-Moro. (2008) Tratamiento de la enfermedad pulmonar obstructiva crónica leve. Medicina Clínica 130:17, pages 661-665.
Crossref
Crossref
J.L. Izquierdo Alonso, J.M. Rodríguez González-Moro, P. de Lucas Ramos, A. Martín Centeno & E. Gobartt Vázquez. (2008) ¿Ha cambiado el manejo de la EPOC en España? Resultados de un estudio multicéntrico comunitario (VICE). Revista Clínica Española 208:1, pages 18-25.
Crossref
Crossref
Antoni Sicras-Mainar, Soledad Velasco-Velasco, Josep Ramon Llopart-L?pez, Ruth Navarro-Artieda & Luis De Haro-Mart?. (2007) Estimaci?n de la morbilidad, el uso de recursos y los costes de los sujetos en tratamiento con bromuro de tiotropio para la enfermedad pulmonar obstructiva cr?nica en un ?mbito poblacional espa?ol. Atenci?n Primaria 39:10, pages 547-555.
Crossref
Crossref
Antoni Sicras Mainar, Ruth Navarro Artieda, Jaime Fern?ndez de Bobadilla & Mercedes Garc?a Vargas. (2007) Estimaci?n de la presencia de eventos cardiovasculares y costes directos asociados a la enfermedad pulmonar obstructiva cr?nica en un ?mbito ambulatorio. Medicina Cl?nica 128:8, pages 317-318.
Crossref
Crossref
Marc Miravitlles, Jesús Molina & Max Brosa. (2007) Eficacia clínica del moxifloxacino en el tratamiento de las agudizaciones de la bronquitis crónica. Revisión sistemática y metaanálisis. Archivos de Bronconeumología 43:1, pages 22-28.
Crossref
Crossref
Marc Miravitlles, Jesús Molina & Max Brosa. (2007) Clinical Efficacy of Moxifloxacin in the Treatment of Exacerbations of Chronic Bronchitis: A Systematic Review and Meta-Analysis. Archivos de Bronconeumología ((English Edition)) 43:1, pages 22-28.
Crossref
Crossref
Joan B. Soriano & Jos? Luis Izquierdo Alonso. (2006) EPOC en la vida y en la muerte. Archivos de Bronconeumolog?a 42:9, pages 421-422.
Crossref
Crossref
Joan B. Soriano & Jos? Luis Izquierdo Alonso. (2006) Chronic Obstructive Pulmonary Disease in Life and Death. Archivos de Bronconeumolog?a ((English Edition)) 42:9, pages 421-422.
Crossref
Crossref
Felip Burgos. (2006) ?Son compatibles la calidad y el uso extensivo de la espirometr?a?. Archivos de Bronconeumolog?a 42:7, pages 311-313.
Crossref
Crossref
Felip Burgos. (2006) Are Quality and the Extensive Use of Spirometry Compatible?. Archivos de Bronconeumolog?a ((English Edition)) 42:7, pages 311-313.
Crossref
Crossref
M. Miravitlles, C. de la Roza, K. Naberan, M. Lamban, E. Gobartt, A. Mart?n & K.R. Chapman. (2006) Problemas con el diagn?stico de la EPOC en atenci?n primaria. Archivos de Bronconeumolog?a 42:1, pages 3-8.
Crossref
Crossref
M. Miravitlles, C. de la Roza, K. Naberan, M. Lamban, E. Gobartt, A. Mart?n & K.R. Chapman. (2006) Attitudes Toward the Diagnosis of Chronic Obstructive Pulmonary Disease in Primary Care. Archivos de Bronconeumolog?a ((English Edition)) 42:1, pages 3-8.
Crossref
Crossref
J.L. Izquierdo Alonso & R. Arroyo-Espliguero. (2005) EPOC y riesgo cardiovascular. Archivos de Bronconeumolog?a 41:8, pages 410-412.
Crossref
Crossref
J.L. Izquierdo Alonso & R. Arroyo-Espliguero. (2005) Chronic Obstructive Pulmonary Disease and Cardiovascular Risk. Archivos de Bronconeumología ((English Edition)) 41:8, pages 410-412.
Crossref
Crossref
J. de Miguel D?ez. (2005) Health Care Costs of Asthma and Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumolog?a ((English Edition)) 41:5, pages 239-241.
Crossref
Crossref
J. de Miguel D?ez. (2005) Farmacoeconom?a en el asma y en la EPOC. Archivos de Bronconeumolog?a 41:5, pages 239-241.
Crossref
Crossref